David R Houck

Title: David R. Houck: Innovator in Erythropoietin Modulation

Introduction

David R. Houck is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of biochemistry, particularly in the development of compounds that enhance the biosynthesis of erythropoietin. His work is crucial for advancing medical treatments related to blood production and anemia.

Latest Patents

David R. Houck holds a patent for "Tetracyclic compounds for enhancing biosynthesis of erythropoietin." This invention provides a compound in substantially pure form with a specific structure that allows for the modulation of cellular expression of the mammalian gene encoding erythropoietin. The patent outlines the various configurations of the compound, emphasizing its potential therapeutic applications.

Career Highlights

David R. Houck is associated with Osi Pharmaceuticals, Inc., where he has been instrumental in research and development efforts. His innovative approach to biochemistry has led to advancements in understanding how erythropoietin can be effectively synthesized and utilized in medical treatments.

Collaborations

Throughout his career, David has collaborated with notable colleagues, including Jonathan G. Williams and David Edward Smith. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic compounds.

Conclusion

David R. Houck's contributions to the field of erythropoietin modulation through his innovative patent highlight his role as a significant inventor in biochemistry. His work continues to influence medical research and treatment options for conditions related to blood production.